Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The company also reported Q2 earnings results.

Benzinga

Nasdaq Tumbles 1.5%; BBQ Holdings Shares Spike Higher

U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 1.5% on Tuesday.

Benzinga

Here's Why Advanced Micro Devices, Nvidia Stock Must Hold These Key Levels

After Micron Technology Inc. (NASDAQ: MU) released weak fourth-quarter guidance, Advanced Micro Devices Inc.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

After the Bear Market Rally What Comes Next?

The stock market is in the midst of an impressive and blistering rally. From the mid-June lows, the S&P 500 (SPY) is up 14%, while the Nasdaq Composite is closing in on a 20% gain. Some of the factors behind this rally are extreme bearish positioning, better than expected economic…

StockNews.com

Can PubMatic Weather Macro Issues? Analysts Remain Bullish Citing Potential Growth Opportunities

Here is what analysts are saying about digital advertising company PubMatic Inc.

Benzinga

Aspen's (AZPN) Q4 Earnings Beat Estimates, Revenues Up Y/Y

Aspen Technology (NASDAQ: AZPN) reported fourth-quarter fiscal 2022 non-GAAP earnings of $2.43 per share, beating the Zacks Consensus Estimate by 13%. The company reported non-GAAP earnings of 38 cents per share in the year-ago quarter.

Benzinga

AquaBounty Technologies, Inc. (AQB) Reports Q2 Loss, Misses Revenue Estimates

AquaBounty Technologies, Inc. (NASDAQ: AQB) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

EXCLUSIVE: Colombia Is About To Legalize Cannabis - And Exports May Land On Your Doorstep Soon, This CEO Says

Andres Fajardo is the CEO of Clever Leaves Holdings Inc. (NASDAQ: CLVR), one of the largest cannabis companies with operations in Canada, Colombia, Germany, Portugal and the United States.

Benzinga

4 Analyst Takeaways From Upstart's Earnings Call Following 2Q Results

Upstart Holdings Inc (NASDAQ: UPST) reported total revenue of $228 million for the second quarter, up 18% year-on-year. The company’s results were broadly in-line with its preannouncement in July. Piper Sandler On Upstart Holdings

Benzinga

Plug Power Q2 Earnings On Deck: What To Watch For After The Bell

Plug Power Inc. (NASDAQ: PLUG) shares have rallied more than 35% over the last month. With earnings due after the bell on Tuesday, Aug. 9, here's a look at what to expect and a rundown of what caused the recent surge.

Benzinga

Super Bullish Or Bearish On Tesla Or Apple? These New ETFs Are For You

A leader in leveraged and inverse and thematic ETFs is launching new investment options for investors looking to place bets for or against two of the largest and most well-known companies in the world. Here are the details.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022

Benzinga

AFC Gamma Q2 2022 Net Income Grows 147%, What About Distributable Earnings?

AFC Gamma, Inc. (NASDAQ: AFCG) released its results for the second quarter of 2022, revealing net income of $11.4 million in Q2 2022, or $0.58 per basic weighted average share of common stock, an increase of 147% compared to

Benzinga

Why U.S. Stocks Are Trading Mixed; Labor Costs Increase Higher-Than-Expected In Q2

U.S. stocks traded mixed this morning, with the Nasdaq dropping around 90 points on Tuesday.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Apple Stock Readies For Pullback: What To Watch From The Market Leader

Apple, Inc (NASDAQ: AAPL) was trading about 0.7% down in the premarket on Tuesday, dragging the S&P 500 about 0.12% lower.

Benzinga

As Curaleaf Taps Ex Jushi & Clever Leaves Executives Other Big Cannabis Players Also Make Key Leadership Changes

As Benzinga Cannabis Capital Conference returns on September 13-14 to Chicago, gathering top CEOs, investors and leader

Benzinga

SYTA: UPDATE: Siyata issues announcements highlighting growing partnerships and distribution channels that is laying the foundation for future growth.

By Thomas Kerr, CFA NASDAQ:SYTA READ THE FULL SYTA RESEARCH REPORT

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Benzinga Before The Bell: Tesla's China Sales Plunge, Snap Rolls Out Parental Control Features, White House Unaware of Raid On Trump's Mar-a-Lago And Other Top Financial Stories Tuesday, August 9

CNBC

Benzinga

Robinhood, Procter & Gamble And 3 Other Big Stocks Insiders Are Selling

U.S. crude oil futures traded mostly lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D.

Benzinga

U.S. Stock Futures Edge Higher; Crude Oil Drops

Pre-open movers

Benzinga

GameStop, Signify Health And Some Other Big Gainers From Monday

U.S. stocks closed mixed on Monday. Here is the list of some big stocks moving higher in the previous session.

Benzinga

Earnings Scheduled For August 9, 2022

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

Benzinga

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

1 … 313 314 315 316

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.